Skip to main content
. Author manuscript; available in PMC: 2022 Jun 13.
Published in final edited form as: Lancet Haematol. 2021 Mar;8(3):e205–e215. doi: 10.1016/S2352-3026(20)30394-X

Table 2.

Hazard ratios for Overall Survival by DRSS* stratum

Derivation cohort Tuning cohort Geographic validation cohort
HR (CI 95%) p-value HR (CI 95%) p-value HR (CI 95%) p-value
Low reference reference reference
Intermediate-1 1·26 (1·17, 1·36) < 0·0001 1·25 (1·14, 1·37) < 0·0001 1·48 (1·17, 1·88) 0·0011
Intermediate-2 1·53 (1·42, 1·66) < 0·0001 1·52 (1·38, 1·67) < 0·0001 1·62 (1·27, 2·08) < 0·0001
High 2·03 (1·86, 2·22) < 0·0001 2·04 (1·83, 2·28) < 0·0001 2·61 (2·01, 3·39) < 0·0001
Very High 2·87 (2·63, 3·13) < 0·0001 2·90 (2·62, 3·22) < 0·0001 3·70 (2·88, 4·74) < 0·0001
*

The full multivariable results for OS, relapse incidence and non-relapse mortality are presented in appendix p. 5, 7–8

OS – overall survival; CI – confidence interval; HR – hazard ratio